戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                   Therefore, we developed (1) a GSH-based photoaffinity probe (GSTABP
2                                        Here, we developed 3D cell-line-based models of human syncytio
3                                              We develop a Bayesian semiparametric model, which combin
4 rumen fluke infection, it is imperative that we develop a better understanding of the basic biology o
5                                         Here we develop a biphasic hydrogel methodology, which along
6                                        Here, we develop a chemical proteomics approach relying upon p
7                                              We develop a connectivity measure that successfully clas
8                                        Here, we develop a convenient (17)O nuclear magnetic resonance
9                                        Here, we develop a flexible architecture for computing damages
10                                       Hence, we develop a flexible Bayesian variable selection model
11                                        Here, we develop a framework for designing marine reserve netw
12                                     Finally, we develop a GPC2-directed antibody-drug conjugate that
13                                        Here, we develop a heterogeneous photonic integration platform
14                                              We develop a hierarchical pipeline, ThreaDomEx, for both
15 t samples collected within 4 y of the spill, we develop a Macondo oil "fingerprint" and conservativel
16                                              We develop a mathematical model of the function of the 1
17   Building on research in social psychology, we develop a mathematical model showing how conditioning
18 o explore the functional importance of 5hmU, we develop a method for the genome-wide mapping of 5hmU-
19                                         Here we develop a method to measure the electron and hole def
20                                        Here, we develop a method to quantify errors in synthetic DNA
21                                              We develop a method to reconstruct, from measured displa
22                                              We develop a methodology to unveil the signals that are
23                                         Here we develop a microprism-based cellular imaging approach
24                                        Next, we develop a modeling framework that leverages transfer
25 on in soils are under increasing scrutiny as we develop a more comprehensive understanding of global
26                                        Here, we develop a more particularistic and mechanistic evolut
27 ly not achievable using traditional methods, we develop a multi-sample-based method.
28  scenario-based life cycle assessment (LCA), we develop a multiobjective optimization model to system
29 ural errors, diagnosed using error breeding, we develop a new forecast approach that combines dynamic
30                                         Here we develop a new method for total transcriptome profilin
31                                        Here, we develop a new mouse model to transfer genes specifica
32                                         Here we develop a novel Bayesian model to simultaneously esti
33                                              We develop a pore recognition approach to quantify simil
34                                              We develop a quantitative model that accounts for this e
35                                         Here we develop a radiolabeled camelid single-domain antibody
36                               In this paper, we develop a random forest model incorporating aerosol o
37                                        Here, we develop a robust bioinformatics pipeline exploiting H
38                                        Here, we develop a screening strategy for modulators of ATP-PR
39                                         Here we develop a simple and efficient crosstalk reduction ap
40                             To capture this, we develop a simple geometric measure, inness, that maps
41                                In this work, we develop a simple variational approach allowing one to
42                                     Finally, we develop a statistical model that incorporates the unc
43                                              We develop a statistical model to predict June-July-Augu
44                                              We develop a statistical nondeterministic model, capable
45                                        Here, we develop a statistical pipeline to assess statistical
46                                        Here, we develop a statistically founded non-coding driver-det
47                                         Here we develop a stochastic evolutionary model and show how
48                               In this paper, we develop a suite of methods, grounded in information t
49                 Based on these observations, we develop a summative model wherein the P-body assembly
50 f polyacrylamide gel electrophoresis (PAGE), we develop a technique for fabrication of PAGE molecular
51                               In this paper, we develop a theoretical framework to investigate which
52                                In this work, we develop a theoretical model describing the physical m
53                                              We develop a theory of the ballistic-to-viscous crossove
54                                              We develop a transcriptional predictor of immunotherapy
55                                              We developed a 16-item model.
56                                              We developed a baboon model for IUGR studies using a mod
57  To gain insight into the TolA-pIII complex, we developed a bacterial two-hybrid approach, named Oxi-
58                               In this study, we developed a biomimetic microfluidic tumor microenviro
59                                  Previously, we developed a biophysically-based model of a binaural b
60 nce requirements within regulatory elements, we developed a bisulfite-mediated nucleotide-conversion
61                     First, in February 2016, we developed a causality framework that defined question
62                                              We developed a cell delivery strategy based on a supramo
63 in the caudate, amygdala, and visual cortex, we developed a classifier based on the dogs' subsequent
64                                        Thus, we developed a clinically-relevant animal model for TON
65         To quantify the substructure of FAs, we developed a clustering method based on expectation ma
66                               In this study, we developed a completely non-destructive strategy using
67 ases severity of retinopathy of prematurity, we developed a composite rat model of UPI and oxygen-flu
68 equires multiple steps of data manipulation, we developed a computational approach (bootstrapping) to
69                                              We developed a computational model of spinal circuits co
70                                        Here, we developed a CRISPR-Cas9-based 'gene drive array' plat
71                                       First, we developed a custom script that can detect intergenic
72                     To address this problem, we developed a data-driven approach to integrate and ana
73         To identify unknown vectors of Zika, we developed a data-driven model linking vector species
74                                              We developed a derivation model to determine the relativ
75                                    Recently, we developed a DNA walking system for the detection and
76 m the coordinated activity of multiple SCPs, we developed a dynamic enrichment algorithm that flexibl
77                                              We developed a dynamic multimedia fate and transport mod
78                                  METHODS AND We developed a dynamic transmission model of multi-strai
79                                In this work, we developed a field effect transistor (FET) biosensor u
80                                              We developed a filter-based feature selection method for
81                                              We developed a flexible Bayesian statistical approach to
82                            For our workflow, we developed a flexible tool for counting the number of
83                                              We developed a fluctuation test based on reversion to fl
84                                              We developed a genetic toolkit to study MT dynamics and
85                                         Here we developed a genome-wide functional screen to interrog
86                                              We developed a Gibbs sampling Markov chain Monte Carlo a
87 mitations of existing computational methods, we developed a global network random walk model for pred
88 atiotemporal control of mitotic progression, we developed a high-content analysis (HCA) approach that
89                                In this work, we developed a high-density SNP array with 690,662 uniqu
90 N-chlorinated dipeptides in authentic water, we developed a high-performance liquid chromatography-ta
91                     To address this problem, we developed a highly multiplexed single-cell DNA sequen
92 ribution of the TL to intrinsic termination, we developed a kinetic assay that distinguishes effects
93                                 Furthermore, we developed a kinome selective irreversible inhibitor 4
94                                        Here, we developed a label-free technique to determine the spa
95 silon-GG epitope recognized during IAP, here we developed a large-scale FASP method (LFASP) for diges
96                                              We developed a Markov-based microsimulation model, which
97                         To investigate this, we developed a mathematical model of the adrenal steroid
98                                              We developed a mathematical model that captures the beha
99                                Additionally, we developed a mathematical model, parameterized by cell
100                                              We developed a membrane-permeant, photoactivatable PI(4,
101                                         Here we developed a Meso Scale Discovery (MSD)-based screenin
102 hydrostatic pressure-induced edema in vitro, we developed a method of applied pressure to the basolat
103                                              We developed a method to directly capture lipid antigens
104                                              We developed a method to estimate glass transition tempe
105                 As a step towards this goal, we developed a method to examine whether individual gene
106 th as an indirect measure for shape readout, we developed a methodology, DNAphi, for predicting EP in
107                                      Herein, we developed a model of hematogenous infection in which
108                                              We developed a model to estimate GPP from the tower-base
109                             In this article, we developed a model-based clustering method and an R fu
110                                      Herein, we developed a more sustainable method to produce silico
111                                        Here, we developed a mouse model to study forelimb adaptation
112 chanisms mediating neuroblastoma metastasis, we developed a mouse model using intracardiac injection
113                                    Moreover, we developed a multiplex transcription activator-like ef
114                                              We developed a multiscale model of fibrinolysis that inc
115                                  To this end we developed a nanoparticle (NP) platform, which is spec
116                       To address this issue, we developed a nanoparticle based platform, called nanoa
117                                In this paper we developed a new algorithm called ESPRIT-Forest for pa
118                               In this study, we developed a new analytical method that combines magne
119                                              We developed a new BMI that allows arbitrarily fast cont
120 atistical analysis of high-dimensional data, we developed a new Debiased Sparse Partial Correlation a
121                                              We developed a new MALS methodology that has overcome th
122                                              We developed a new method (called REPPS) for incorporati
123                                        Here, we developed a new method and an R package, to easily in
124                     To solve such a problem, we developed a new method called Optimistic Protein Asse
125                                              We developed a new method to quantify [K(+)] from T-wave
126 e of neutrophils in LPS-induced endotoxemia, we developed a new mouse model, PMN(DTR) mice, in which
127                                              We developed a new multivariable linear model for GFR us
128 fectious-RNA incorporation into new virions, we developed a new recombinant reovirus S1 gene that exp
129                                              We developed a new scoring system for calculating morbid
130                             To address this, we developed a new single-strand consensus sequencing as
131                   In pursuit of these goals, we developed a new synthetic approach that enables facil
132                                        Here, we developed a novel alignment-free method, ChimeRScope
133                                              We developed a novel analytical framework for mapping an
134                                        Here, we developed a novel and simple strategy to greatly enha
135 unanswered questions about these inhibitors, we developed a novel approach to map the distribution of
136                                              We developed a novel approach towards the identification
137                   To investigate this claim, we developed a novel assay that allows for parallel prof
138 fects in mice generalize to another species, we developed a novel Bace1(-/-) rat line using zinc-fing
139                                              We developed a novel hand-rearing paradigm in European s
140                                 To this end, we developed a novel hydrosoluble zwitterionic MMP inhib
141                                              We developed a novel method to compute gene-level P-valu
142                                              We developed a novel methodology for burden estimation a
143                                              We developed a novel mirror box illusion to investigate
144 f the raft environment on prion propagation, we developed a novel model for prion infection where cel
145                                              We developed a novel model of cancer-induced BTP using f
146                                              We developed a novel mouse strain in which the human low
147                                        Here, we developed a novel receptor-ligand model of the adenos
148                                              We developed a novel score to predict posttransplant out
149 esentative of community exposure; therefore, we developed a novel spatial phytosampling methodology t
150                                              We developed a panel of tunable expression platforms for
151               Using gamma-MSH as a template, we developed a peptide, [Leu(3), Leu(7), Phe(8)]-gamma-M
152                                              We developed a platform for microfluidics-assisted cell
153                                         Here we developed a population-level microsatellite profiling
154              For efficient synthetic access, we developed a practical mixed solid- and solution-phase
155      To investigate their cellular dynamics, we developed a quantitative assay, which detects differe
156                  To address these questions, we developed a quantitative polymerase chain reaction-ba
157     To enable rapid collection of such data, we developed a relatively simple method using high-preci
158                                In this work, we developed a rice gene co-expression network for anthe
159                               In conclusion, we developed a robust ultrasound-based elastography meth
160                                        Here, we developed a sensitive and accurate multiplex miRNA pr
161                                        Here, we developed a sensitive sandwich enzyme-linked immunoso
162                            To gain insights, we developed a signature, "CA20", comprising centrosome
163                              INTERPRETATION: We developed a simple method that can be easily integrat
164                          2016, 144, 204105), we developed a simple method that resolves these issues.
165                                              We developed a simple model that explains both dissipati
166                                   Therefore, we developed a simple quantitative framework to select a
167                                              We developed a single cell-based experimental system fro
168                            Toward this goal, we developed a software pipeline named digit that implem
169                                              We developed a statistical classification framework that
170                                  METHODS AND We developed a stochastic compartmental model representi
171 s that explore pH and particle size effects, we developed a stochastic simulation that exactly mimics
172                                              We developed a strategy for precise gene editing that do
173                  To overcome these barriers, we developed a strategy to macroencapsulate islets from
174                                   Previously we developed a structure-based method for prediction of
175                  To identify low KM chimeras we developed a suitable bacterial selection system (E. c
176                                         Here we developed a surface fluorination process to form a ho
177      To address these clinical shortcomings, we developed a synthetic polycation, Universal Heparin R
178                    To overcome this barrier, we developed a synthetic-biology approach based on a tec
179              Using a high-throughput method, we developed a T7 phage display cDNA library derived fro
180 atic environments (surface and groundwater), we developed a technique for field continuous measuremen
181                                        Here, we developed a technique for quantitative analysis using
182 d safety of engineered T-cell immunotherapy, we developed a therapeutic transgene with 4 components:
183  CD39 in an in vivo cerebral ischemia model, we developed a transgenic mouse expressing human CD39 (h
184                                              We developed a transmission-dynamic model on a dynamic n
185                                              We developed a two-alternative forced-choice task in an
186 wing ischemia are limited in their efficacy, we developed a unique approach to protect the heart by t
187                                              We developed a WAFEX-guided principal analysis and unrav
188                                        Here, we develop Act-seq, which minimizes artificially induced
189                                         Here we develop AcTakines (Activity-on-Target cytokines), opt
190                To exploit this dual concept, we developed agents exerting partial FXR agonism and sEH
191                                              We develop an algorithm named dpath that applies the con
192                                        Here, we develop an algorithm to predict missing links based o
193                                         Here we develop an alternative inhibitor for miRNAs, termed '
194                                         Here we develop an analytical approach that corrects a major
195                                         Here we develop an animal model utilizing direct ZIKV inocula
196                                              We develop an automated analysis pipeline to analyze and
197                                      Herein, we develop an electrochemical sacrificial-template strat
198                              As a byproduct, we develop an order-parameter classification scheme that
199 nable precision analysis of R-loops in vivo, we develop an RNase-H-based approach; this reveals predo
200 ate candidate selection for experimentation, we developed an algorithm called GRACE (Gene Regulatory
201                                        Here, we developed an algorithm, TransDetect, able to predict
202                                    Recently, we developed an antibody-based PD-L1-targeted SPECT agen
203                                              We developed an approach to examine emergent behaviors t
204 al variants and their effects on phenotypes, we developed an approach to mapping structural variants
205                                In this work, we developed an aptamer/graphene-based electrochemical b
206                                              We developed an assay for the high-throughput search for
207                                     Finally, we developed an assay to assess whether neurons expressi
208                                              We developed an efficient cell culture system and isolat
209 less restricted mutual exclusivity analysis, we developed an efficient method to estimate P -values w
210                                              We developed an electrophysiology-based classification o
211                                              We developed an evolutionary game theory model using Lot
212                 To overcome this limitation, we developed an ex vivo culture method of the mammary gl
213                                        Here, we developed an immunotherapeutic regimen capable of eli
214                                              We developed an in silico model of two-dimensional actom
215                                              We developed an individual-based TB transmission model r
216 d previously implicated genes such as CDKN1A We developed an innovative approach that integrates sing
217                              In this regard, we developed an innovative method for the inner-recyclin
218     Using an instrumental variable approach, we developed an instrument for variations in local pollu
219       To investigate longitudinal responses, we developed an intravital serial imaging approach that
220                       To address this issue, we developed an ITC empirical response model (ITC-ERM) t
221                                    Moreover, we developed an oligonucleotide retrieval immunoprecipit
222 esponded with the hand being near an object, we developed an online scaling feature in the BCI system
223                                              We developed an RNA-sequencing-based pipeline to discove
224                                        Here, we develop and apply methods for cortex-wide Ca(2+) imag
225                                         AIM: We developed and characterized a robust, consistent, and
226                       Based on this dataset, we developed and compared 2-class and 3-class DILI predi
227                                        Here, we developed and comprehensively characterized a cellula
228 te the diagnosis of compromised individuals, we developed and independently cross-validated a biomark
229                                              We developed and performed resistome analysis, an unbias
230 spending by individuals over many years, and we developed and used an individual-level matching metho
231                                              We developed and validated a multivariate whole-blood mR
232                              INTERPRETATION: We developed and validated a novel clinical prediction m
233                                              We developed and validated a rapid, sensitive, and robus
234 roof of concept for anti-TRBC immunotherapy, we developed anti-TRBC1 chimeric antigen receptor (CAR)
235                                              We developed approaches to management based on the study
236                                   Therefore, we developed biodegradable polymeric microspheres for th
237                To investigate this question, we developed breast cancer cell lines expressing an indu
238                           BACKGROUND & AIMS: We developed comprehensive models to determine risk of B
239                                              We developed core shell lipid-polymer hybrid nanoparticl
240                                         Here we developed covariates for multiphenotype studies (CMS)
241                 Based on these observations, we developed cPPA programmable microcapsules whose paylo
242           By engineering C-terminal charges, we develop CRY2high and CRY2low with elevated or suppres
243                                              We developed DC nanozymes with high enzymatic activity a
244 in next-generation sequencing (NGS) screens, we developed DOMINO, a tool assessing the likelihood for
245                                        Here, we develop flat and thin phase-conjugate nanostructures
246                                              We developed fMRI markers predicting moment-by-moment in
247   To improve our previous vaccine candidate, we developed four new candidates that incorporate modifi
248 ess issues identified with existing methods, we developed GB-eaSy, a GBS bioinformatics workflow that
249                                              We develop Genome-wide Reconstruction of Complex Structu
250                                              We developed inducible synthetic gene circuits that gene
251                                              We developed inoFISH to directly visualize and quantify
252 y miss these position-specific short motifs, we developed kpLogo, a probability-based logo tool for i
253  bottleneck of modern untargeted lipidomics, we developed LipidHunter, a new open source software for
254                                              We developed live-cell imaging assays which show that te
255                                         Here we develop local self-uniformity (LSU) as a measure of a
256                                         Here we develop mathematical models of Tfh cells in germinal
257                                              We developed mathematical models to study two different
258                                         Here we develop methods for expression of fluorescent protein
259 ion accuracy to guide platform optimization, we develop methods to standardize holograms for the purp
260 cies survive and persist outside their host, we developed methods to more effectively culture C. auri
261                                              We developed molecular assays and portable optical imagi
262                                              We developed new genomic measures of damaging passenger
263         To suppress this survival mechanism, we developed new thiourea quinazoline derivatives that a
264 and improved visualization of tumor margins, we developed new viral-based platforms with 2 specific g
265                                              We developed novel genetically encoded ER-targeted low-a
266                                         Here we developed novel replicating poxvirus NYVAC-based HIV/
267                                              We develop numerical simulations of Joule heating-enhanc
268                        To address this issue we developed OncoScore, a text-mining tool that ranks ge
269                                              We developed prediction models by means of an election d
270                    The performance estimates we develop provide important context to interpret clonal
271                          Using this approach we developed quantitative motifs for a selection of kina
272             To quantify how curvature forms, we developed QuASAR (quantitative analysis of sacculus a
273                         In the present work, we developed regression between ovary development and th
274                                              We developed risk maps for autochthonous CHIKV transmiss
275          To better investigate this process, we developed sensitive assays that use the fluorescein a
276                                         Here we develop several mouse models in which hypothalamic st
277                                        Here, we develop skin grafts from mouse and human epidermal pr
278                                              We developed SLICE, a novel algorithm that utilizes sing
279                                              We developed software that automatically analyzes the se
280                                              We developed statistical models relating seasonal temper
281                                        Here, we develop such a method, termed APEX-RIP, which combine
282                                         Here we develop surrogate Wnt agonists, water-soluble FZD-LRP
283 pical clinical reasons for switching agents, we developed "switching rules" at both 3 and 6 months af
284 sed in conjunction with a software tool that we developed that converts an arbitrary pattern into DNA
285                               In this review we develop the argument that cholestatic liver diseases,
286                                              We develop the heterogeneous BLAST (H-BLAST), a fast par
287          To efficiently optimise the system, we develop the Optometrist Algorithm, a stochastic pertu
288 and V3 regions and the gp120-gp41 interface, we developed the CZA97 SOSIP.v4.2-M6.IT construct.
289                                              We developed the IsotopicLabelling R package, a tool abl
290                                              We developed the methodology for and investigated the ut
291                                              We developed the Molecular Biology of the Cell Ontology
292        Upon completion of follow-up studies, we developed the working model that synaptic plasticity
293                                     Finally, we developed this concept by performing the reductive al
294 larify the underlying regulatory mechanisms, we developed three biologically anchored mathematical mo
295                                        Here, we developed transgenic dy2J mice with muscle-specific e
296                                              We developed Triplex by constructing an rMVA encoding 3
297                                In this work, we develop two in vitro models to simulate the process o
298                            Toward this goal, we developed two mouse lines, including one harboring th
299                                              We developed urinary metabolite models for each diet and
300                                              We developed Yet Another RNA Normalization software pipe

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top